Clinical Trial Update: Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM [Phase 3]

View source ↗

Summary

Phase 3 trial assessing dasiglucagon for treatment of hypoglycemia in type 1 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• dasiglucagon (dasiglucagon)

Snippet

Sponsor: Zealand Pharma | Conditions: Hypoglycemia, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2021-05-19